Other Open Access
PREFER - Patient Preferences in benefit risk assessments during the drug life cycle
PREFER is developing recommendations for when and how patient preferences can contribute to industry, regulatory and HTA decision making throughout the medical product life cycle. We include patient stakeholders at every level of the project. This pdf booklet includes a list of our publications in chronological order (latest first), with abstracts and links to full text. The list was updated on 23 September 2021.
IMI PREFER PUBLICATIONS 2017-2021 23-09-2021 2.pdf
IMI PREFER PUBLICATIONS 2017-2021 23-09-2021.pdf